Cure Opportunities


Stem cells: more than a simple cell.

Stem cells are tremendously small & incredibly powerful, too valuable to be wasted. Clinical trials analyse new medical treatments, checking their safety, efficacy and potentially adverse effects in humans. So far more than 36’000 Cord Blood Stem Cell transplantations have been performed in the World.

Stem cells: too valuable to be wasted.


Mesenchymal Stem Cells (MSCs) are responsible for the formation of bone, cartilage and other types of connective tissue cells in our bodies. MSCs are involved in regenerative medicine clinical trials, with the ultimate goal of replacing, repairing or supporting regeneration of living functional cells or tissues.

Haematopoietic Stem Cells from Umbilical Cord Blood are capable of rebuilding our immune and haematopoietic system. They have been used for more than 26 years to treat more than 70 different diseases.

Umbilical Cord Blood is becoming the preferred source of Haematopoietic Stem Cells because:

They are younger than any other adult Stem Cell, meaning they have a better ability to multiply and specialise.

The rate of ‘Graft vs. Host Disease’ is lower. This complication (also called rejection) is associated with allogeneic Stem Cell transplantations.

Their collection is a very easy and risk-free process.

5’400+ trials
with Stem Cells.


Both Haematopoietic and Mesenchymal Stem Cells are being actively researched for the treatment of numerous diseases, such as Cerebral Palsy, Type 1 Diabetes, Brain Disorders, Heart Conditions, Auto-immune Disorders, Liver Disorders and Neurological Diseases.